Cancer Risk Tests
GENDIA also offers a universal CANCER RISK TEST that detects both sequence variants and larger deletions-duplications in 30 cancer genes, including BRCA1, BRCA2, APC, ATM, BAP1, BARD1, BMPR1A, BRIP1, CDH1, CDKN2A CDK4, CHEK2, EpCAM, GREM1, MLH1, MSH2, MSH6, MITF, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11 and TP53.
Germline mutations in these genes are often involved in hereditary cancers, particularly cancer of the breast, ovaries, uterus, intestines, stomach, pancreas, skin and prostate.
More info is available on: http://www.kankerscreening.net
The test requires saliva in an Oragene recipient available at GENDIA.
The price varies on the analysis wanted.
Price ListCancer Risk Tests
Many single cancer gene tests are available in another table: Molecular Tests.
Many multigene cancer panels are available in another table: Next Generation and Sanger Sequencing Platforms.